000516 Xi'An International Medical Investment
- 5.76
- +0.09+1.59%
Xi'An International Medical Investment News
International Medicine: Announcement on the cancellation of the pledge of part of the controlling shareholder\'s shares
International Medicine: An indicative announcement on lifting the listing and circulation of restricted shares during the second restricted sales period of the 2022 Restricted Stock Incentive Plan
International Medicine: Announcement on the controlling shareholder\'s share pledge
International Medicine: Announcement on the progress of share repurchases
International Medicine: 000516 International Medical Investor Relations Management Information 20241029
International Medicine: 000516 International Medical Investor Relations Management Information 20241028
International Medicine: Announcement on the controlling shareholder\'s share pledge
International Medicine: third quarter report 2024
International Medicine: An indicative announcement on lifting the listing and circulation of restricted shares during the third restricted sales period of the 2021 Restricted Stock Incentive Plan
International Medicine: Announcement on the progress of share repurchases
International Medicine: Announcement on the cancellation of the pledge of part of the controlling shareholder\'s shares
International Medicine: Announcement on the progress of share repurchases
International Medicine: 000516 International Medical Investor Relations Management Information 20240829
International Medicine: Revised Comparative Table of the “Accountability System for Major Errors in Annual Report Information Disclosure”
International Medicine: 2024 Semi-Annual Report Summary
International Medicine: Investor Relations Management System
International Medicine: Board Audit Committee Annual Report Work Procedure
International Medicine: Accountability System for Major Errors in Annual Report Information Disclosure
International Medicine: Revised Comparative Table of the “External Guarantee Management System”
International Medicine: Revised Comparative Table of the “Investor Relations Management System”
Analysis
Price Target
No Data
No Data